| Trial ID: | L5451 |
| Source ID: | NCT01941199
|
| Associated Drug: |
Da-1229
|
| Title: |
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: DA-1229|DRUG: metformin|DRUG: DA-1229 + metformin
|
| Outcome Measures: |
Primary: AUCĪ,ss of DA-1229 and metformin, up to 168h|Cmax,ss of DA-1229 and metformin, up to 168h |
|
| Sponsor/Collaborators: |
Sponsor: Dong-A Pharmaceutical Co., Ltd.
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-07
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2013-11-27
|
| Locations: |
Clinical Trial Center, Seoul National University Hospital, Seoul, 110-744, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01941199
|
